Synlett 2023; 34(18): 2169-2174
DOI: 10.1055/a-2108-9895
cluster
Modern Boron Chemistry: 60 Years of the Matteson Reaction

N-Functionalization of 1,2-Azaborines

a   Department of Chemistry, Boston College, Chestnut Hill, MA 02467-3860, USA
b   Accent Therapeutics, Inc., 1050 Waltham Street, Suite 201, Lexington, MA 02421, USA
,
Marisol Alvarado
a   Department of Chemistry, Boston College, Chestnut Hill, MA 02467-3860, USA
,
Sarah Ingram
a   Department of Chemistry, Boston College, Chestnut Hill, MA 02467-3860, USA
c   Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
,
Bo Li
a   Department of Chemistry, Boston College, Chestnut Hill, MA 02467-3860, USA
,
Shih-Yuan Liu
a   Department of Chemistry, Boston College, Chestnut Hill, MA 02467-3860, USA
› Author Affiliations
The research reported in this publication was supported by National Institute of General Medical Sciences, (Award Number: 'R01GM136920'), and by Boston College start-up funds. We also acknowledge the NIH-S10 (award: 1S10OD026910-01A1) and the NSF-MRI (award: CHE-2117246) for the support of Boston College’s NMR facilities.


Abstract

General protocols for the N-functionalization of 1,2-azaborines with C(sp3), C(sp2), or C(sp) electrophiles are described. The syntheses of a new parental BN isostere of trans-stilbene and a BN isostere of a lisdexamfetamine derivative were accomplished with the developed methodology.

Supporting Information



Publication History

Received: 04 May 2023

Accepted after revision: 12 June 2023

Accepted Manuscript online:
12 June 2023

Article published online:
31 July 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

  • 2 McConnell CR, Liu S.-Y. Chem. Soc. Rev. 2019;  48: 3436
  • 4 Pan J, Kampf JW, Ashe AJ. III. Org. Lett. 2007; 9: 679
  • 7 McConnell CR, Haeffner F, Baggett AW, Liu S.-Y. J. Am. Chem. Soc. 2019;  141: 9072

    • For a study to access N-functionalized 2,1-borazaronaphthalenes, see:
    • 9a Wang X, Davies GH. M, Koschitzky A, Wisniewski SR, Kelly CB, Molander GA. Org. Lett. 2019; 21: 2880

    • For a study to utilize 1,2-azaborinin-1-yls as anionic nitrogen ligands for main group elements, see:
    • 9b Lindl F, Lamprecht A, Arrowsmith M, Khitro E, Rempel A, Dietz M, Wellnitz T, Bélanger-Chabot G, Stoy A, Paprocki V, Prieschl D, Lenczyk C, Ramler J, Lichtenberg C, Braunschweig H. Chem. Eur. J. 2023; 29: e202203345
  • 12 For a leading reference on oligo(ortho-arylenes), see: Lehnherr D, Chen C, Pedramrazi Z, DeBlase CR, Alzola JM, Keresztes I, Lobkovsky EB, Crommie MF, Dichtel WR. Chem. Sci. 2016; 7: 6357
  • 15 Lamm AN, Liu S.-Y. Mol. BioSyst. 2009; 5: 1303
  • 16 BN-Stilbene {1-[(E)-2-Phenylvinyl]-1,2-dihydro-1,2-azaborinine} (10) In a dry box, an oven-dried 50 mL round-bottomed flask was charged with 2-benzyl-1,2-dihydro-1,2-azaborinine (7)6 (507 mg, 3.00 mmol) and toluene (15 mL), and the mixture was cooled to –30 °C. A 2.5 M solution of BuLi in hexane (1.26 mL, 3.15 mmol) was added at –30 °C, and the resulting mixture was stirred for 20 min while it slowly warmed to RT. Pd2(dba)3 (55 mg, 0.060 mmol), QPhos (170 mg, 0.240 mmol), and β-bromostyrene (476 μL, 3.60 mmol) were added, and the mixture was stirred at 85 °C for 15 h. At the completion of the reaction, the mixture was cooled to RT, then passed through an Acrodisc using CH2Cl2 as solvent. The filtrate was concentrated under reduced pressure, and the crude product was purified by column chromatography (silica gel, 2–10% CH2Cl2–pentane) to give 8 as a white solid; yield: 497 mg (61%). FTIR (thin film): 3059, 3025, 1644, 1611, 1511, 1492, 1401, 1356, 1260, 1117, 1008, 801, 751, 693, 517 cm–1. 1H NMR (500 MHz, CD2Cl2): δ = 7.70 (d, J = 14.5 Hz, 1 H), 7.60–7.54 (m, 2 H), 7.48 (d, J = 7.5 Hz, 2 H), 7.41 (t, J = 7.0 Hz, 2 H), 7.34–7.29 (m, 3 H), 7.25–7.22 (m, 2 H), 7.18–7.16 (m, 1 H), 6.65 (d, J = 14.0 Hz, 1 H), 6.58 (d, J = 11.5 Hz, 1 H), 6.40 (t, J = 7.0 Hz, 1 H), 2.91 (s, 2 H). 11B NMR (160 MHz, CD2Cl2): δ = 37.9. 13C NMR (151 MHz, CD2Cl2): δ = 143.8, 143.0, 136.4, 134.1, 133.9, 131.0 (br), 129.7, 129.4, 128.9, 128.1, 126.8, 124.9, 121.5, 111.8, 27.6 (br). HRMS (DART-TOF): m/z [M + H]+ calcd for C19H19BN: 272.16105, found: 272.16078. In a dry box, an oven-dried 20 mL microwave vial was charged with 8 (360 mg, 1.33 mmol), dodecanol (346 mg, 1.86 mmol), CuBr (19 mg, 0.13 mmol), pyridine (214 μL, 2.66 mmol), di-tert-butyl peroxide (293 mL, 1.59 mmol), and toluene (13 mL), and the mixture was stirred at 90 °C for 1 h, then cooled to RT and the solvent was removed under reduced pressure. The crude oxidized product was purified by column chromatography (silica gel 2–50% Et2O–pentane) to isolate a mixture containing the desired product and other byproducts that was used directly to the next step. In a dry box, an oven-dried 25 mL round-bottomed flask was charged with the mixture of oxidized products and Et2O (10 mL), which was then cooled to –30 °C. LAH (15 mg, 0.40 mmol) was added at –30 °C, and the mixture was stirred for 30 min. A 2.0 M solution of HCl in Et2O (395 μL, 0.790 mmol) was added at –30 °C and the mixture was stirred for 30 min while it slowly warmed to RT. The solvent was removed under reduced pressure, and the crude product was purified by column chromatography (silica gel, 100% pentane to 2% Et2O–pentane) to give 10 as a white solid; yield: 91.3 mg (38% over two steps). FTIR (thin film): 3063, 3022, 2539, 1650, 1604, 1508, 1404, 1262, 1152, 973, 755, 693, 596 cm–1. 1H NMR (500 MHz, CD2Cl2): δ = 7.68–7.64 (m, 2 H), 7.48 (d, J = 14.5 Hz, 1 H), 7.45 (t, J = 8.5 Hz, 2 H), 7.35 (t, J = 7.5 Hz, 2 H), 7.26 (t, J = 7.5 Hz, 1 H), 6.97 (d, J = 10.5 Hz, 1 H), 6.79 (d, J = 14.5 Hz, 1 H), 6.51 (t, J = 6.5 Hz, 1 H), 5.82–4.60 (br, 1 H). 11B NMR (160 MHz, CD2Cl2): δ = 33.2 (d, J = 109 Hz). 13C NMR (151 MHz, CD2Cl2): δ = 144.4, 136.9, 136.4, 134.1, 131.4 (br), 129.3, 127.9, 126.7, 118.8, 113.3. HRMS (DART-TOF): m/z [M + H]+ calcd for C12H13BN: 182.11410, found: 182.11324.
  • 17 Abbey ER, Zakharov LN, Liu S.-Y. J. Am. Chem. Soc. 2008; 130: 7250
  • 18 The crystal structure of BN-stilbene 10 is disordered due to the apparent centrosymmetric nature of the molecule. Nevertheless, the planar geometry of the solid-state structure of 10 is clearly observed.
  • 19 Goodman DW. Pharm. Ther. 2010; 35: 273
  • 20 A similar effect has been reported for the 2,1-borazaronaphthalenes, see ref. 9a.